Sicheng Li Selected Research

Sicheng Li Research Topics

Disease

8	Ischemic Stroke 03/2024 - 01/2020
8	Inflammation (Inflammations) 12/2023 - 01/2020
5	Stroke (Strokes) 07/2023 - 01/2020
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2023 - 12/2020
4	Neoplasms (Cancer) 01/2023 - 11/2018
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2018 - 08/2017
3	Ischemia 12/2023 - 01/2020
3	Wounds and Injuries (Trauma) 11/2023 - 01/2021
3	Brain Injuries (Brain Injury) 08/2022 - 01/2020
2	Chronic Renal Insufficiency 04/2024 - 09/2022
2	Hyperplasia 12/2023 - 08/2019
2	Hypoxia (Hypoxemia) 12/2023 - 11/2023
2	Obesity 01/2023 - 09/2014
2	Neuroinflammatory Diseases 08/2022 - 01/2021
2	Traumatic Brain Injuries (Traumatic Brain Injury) 08/2022 - 08/2022
2	Body Weight (Weight, Body) 01/2022 - 01/2021
2	Weight Loss (Weight Reduction) 11/2018 - 04/2018
1	Atrophy 03/2024
1	Intestinal Fistula 02/2024
1	Fistula 02/2024
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024
1	Dysbiosis 10/2023
1	Infections 10/2023
1	Dyslipidemias (Dyslipidemia) 09/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2023
1	Infarction (Infarctions) 07/2023
1	Multiple Organ Failure (MODS) 05/2023
1	Hypernatremia 05/2023
1	Acute Disease 01/2023
1	Hearing Loss (Hearing Impairment) 01/2023
1	Encephalitis (Encephalitis, Rasmussen) 08/2022
1	Brain Infarction 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021
1	Bites and Stings (Sting) 12/2020

Drug/Important Bio-Agent (IBA)

5	RNA (Ribonucleic Acid)IBA 07/2023 - 01/2020
4	HydrogelsIBA 02/2024 - 12/2021
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2014
3	Particulate MatterIBA 04/2024 - 01/2023
2	SootIBA 09/2023 - 01/2023
2	NitratesIBA 09/2023 - 01/2023
2	Ammonium CompoundsIBA 09/2023 - 01/2023
2	Sulfates (Sulfates, Inorganic)IBA 09/2023 - 01/2023
2	Immune Checkpoint InhibitorsIBA 01/2023 - 11/2018
2	Histone Deacetylases (Histone Deacetylase)IBA 08/2022 - 01/2021
2	Histone Deacetylase InhibitorsIBA 08/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	Therapeutic UsesIBA 12/2021 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2020
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 11/2018
2	LigandsIBA 12/2020 - 05/2018
2	Insulin (Novolin)FDA Link 09/2018 - 08/2017
2	Messenger RNA (mRNA)IBA 12/2015 - 09/2014
1	PeroxiredoxinsIBA 03/2024
1	EkoIBA 03/2024
1	FibrinIBA 02/2024
1	xanthan gum (xanthan)FDA LinkGeneric 02/2024
1	CollagenIBA 12/2023
1	NF-kappa B (NF-kB)IBA 12/2023
1	Oxygen (Dioxygen)IBA 12/2023
1	Glucose (Dextrose)FDA LinkGeneric 11/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023
1	itaconic acidIBA 10/2023
1	Syk KinaseIBA 10/2023
1	LipidsIBA 09/2023
1	oxidized low density lipoproteinIBA 09/2023
1	SaltsIBA 09/2023
1	CholesterolIBA 09/2023
1	LDL CholesterolIBA 09/2023
1	Hazardous Substances (Hazardous Materials)IBA 09/2023
1	HDL CholesterolIBA 09/2023
1	Triglycerides (Triacylglycerol)IBA 09/2023
1	ArginaseIBA 07/2023
1	Transcription Factors (Transcription Factor)IBA 07/2023
1	AcidsIBA 05/2023
1	IronIBA 01/2023
1	Lipid PeroxidesIBA 01/2023
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	CanagliflozinIBA 01/2023
1	Circular RNAIBA 01/2023
1	Air Pollutants (Pollutants, Air)IBA 09/2022
1	STAT1 Transcription FactorIBA 08/2022
1	fludarabineIBA 08/2022
1	histone deacetylase 3IBA 08/2022
1	Neuroprotective AgentsIBA 01/2022
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2022
1	Interleukin-33IBA 01/2022
1	salvinorin AIBA 01/2022
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2022
1	OsteopontinIBA 01/2021
1	QiDiTangShen granulesIBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	AlbuminsIBA 01/2021
1	Mitochondrial DNA (mtDNA)IBA 12/2020

Therapy/Procedure

3	Therapeutics 08/2022 - 11/2018
1	Investigational Therapies (Experimental Therapy) 07/2023
1	Intranasal Administration 01/2022
1	Immunomodulation 01/2022
1	Injections 12/2021